Matteo Pacini

Dr. Matteo Pacini

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2024 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
MPMatteo Pacini
Matteo Pacini
LLLuca Lambertini
Luca Lambertini
GAGiulio Avesani
Giulio Avesani
JAJuan R. Torres Anguiano
Juan R. Torres Anguiano
LMLuca Morgantini
Luca Morgantini
SCSimone Crivellaro
Simone Crivellaro

4 October 2024 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
LLLuca Lambertini
Luca Lambertini
MPMatteo Pacini
Matteo Pacini
RCRuben Sauer Calvo
Ruben Sauer Calvo
LMLuca Morgantini
Luca Morgantini
DCDonato Cannoletta
Donato Cannoletta
SCSimone Crivellaro
Simone Crivellaro

Verified
Journal Article
Open access
PDF file
AFAndrea Fuschi
Andrea Fuschi
PSPaolo Pietro Suraci
Paolo Pietro Suraci
Antonio Luigi PastoreAntonio Luigi Pastore
Antonio Luigi Pastore
YSYazan Al Salhi
Yazan Al Salhi
PCPaola Capodiferro
Paola Capodiferro
Marco RengoMarco Rengo
Marco Rengo
Purpose: The accuracy of multiparametric magnetic resonance imaging (mpMRI) heavily relies on image quality, as evidenced by the evolution of the prostate imaging quality (PI-QUAL) scoring system for the evaluation of clinically significant prostate cancer (csPC). This study aims to evaluate the impact of PI-QUAL scores in detecting csPC within PI-RADS 4 and 5 lesions. Methods: We retrospectively selected from our database all mpMRI performed from January 2019 to March 2022. Inclusion criteria were as follows: (1) mpMRI acquired in our institution according to the technical requirements from the PI-RADS (v2.1) guidelines; (2) single lesion scored as PI-RADS (v2.1) 4 or 5; (3) MRI-TBx performed in our institution; (4) complete histology report; and (5) complete clinical record. Results: A total of 257 male patients, mean age 70.42 ± 7.6 years, with a single PI-RADS 4 or 5 lesion undergoing MRI-targeted biopsy, were retrospectively studied. Of these, 61.5% were PI-RADS 4, and 38.5% were PI-RADS 5, with 84% confirming neoplastic cells. In high-quality image lesions (PI-QUAL ≥ 4), all PI-RADS 5 lesions were accurately identified as positive at the final histological examination (100% of CDR). For PI-RADS 4 lesions, 37 (23%) were negative, resulting in a cancer detection rate of 77% (95% CI: 67.51–84.83). Conclusions: The accuracy of mpMRI, independently of the PI-RADS score, progressively decreased according to the decreasing PI-QUAL score. These findings emphasize the crucial role of the PI-QUAL scoring system in evaluating PI-RADS 4 and 5 lesions, influencing mpMRI accuracy.

25 April 2025 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
MPMatteo Pacini
Matteo Pacini
AZAlessandro Zucchi
Alessandro Zucchi
ASAndrea Salonia
Andrea Salonia
ESEleonora Sollazzi
Eleonora Sollazzi
GMGiada Macrì
Giada Macrì
RBRiccardo Bartoletti
Riccardo Bartoletti

23 July 2024 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
AOAngelo Orsini
Angelo Orsini
GBGabriele Bignante
Gabriele Bignante
FLFrancesco Lasorsa
Francesco Lasorsa
EBEugenio Bologna
Eugenio Bologna
SMSpencer Mossack
Spencer Mossack
RARiccardo Autorino
Riccardo Autorino

1 August 2024 in International braz j urol
Verified
Journal Article
Open access
PDF file
DCDonato Cannoletta
Donato Cannoletta
APAntony Pellegrino
Antony Pellegrino
GPGreta Pettenuzzo
Greta Pettenuzzo
MPMatteo Pacini
Matteo Pacini
RSRuben Calvo Sauer
Ruben Calvo Sauer
SCSimone Crivellaro
Simone Crivellaro
Introduction Vesicovaginal fistula (VVF) is the most common urogenital fistula due to iatrogenic cause, primarily associated with gynecologic surgery (1). Although both conservative and surgical management may be considered, the optimal treatment is still uncertain and several studies were published using different techniques (open, laparoscopic or robotic) and approaches (extravesical, transvesical or transvaginal) (2–5). In this context, we aim to report our initial experience repairing VVF with Single-Port (SP) Transvesical (TV) access.